Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allergan Details Revenue Expectations From Newly Acquired Inamed

This article was originally published in The Gray Sheet

Executive Summary

Allergan expects its recently completed acquisition of Inamed to add $355 mil. to $395 mil. in sales revenue this year
Advertisement

Related Content

Broad Coverage For Lap-Band Helps Grow Allergan’s Obesity Sales
Broad Coverage For Lap-Band Helps Grow Allergan’s Obesity Sales
Allergan builds obesity treatment portfolio
Allergan builds obesity treatment portfolio
Allergan’s Juvederm Dermal Filler Approved, But Market Will Wait
Allergan’s Juvederm Dermal Filler Approved, But Market Will Wait
Mentor silicone submission
Allergan, Inamed unite
Seniors Covered In New Medicare Policy For Bariatric Surgery
Inamed Receives Silicone Breast Implant “Approvable” Letter From FDA
Advertisement
UsernamePublicRestriction

Register

MT023378

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel